心力衰竭基因治疗的现状 - Suppr

Suppr

超能文献

Current Landscape of Heart Failure Gene Therapy.

作者信息

Kieserman Jake M, Myers Valerie D, Dubey Praveen, Cheung Joseph Y, Feldman Arthur M

机构信息

1 Division of Cardiology The Department of Medicine Lewis Katz School of Medicine at Temple University Philadelphia PA.

出版信息

J Am Heart Assoc. 2019 May 21;8(10):e012239. doi: 10.1161/JAHA.119.012239.

DOI:10.1161/JAHA.119.012239

PMID:31070089

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6585330/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7663/6585330/06b56548eeec/JAH3-8-e012239-g001.jpg

相似文献

Current Landscape of Heart Failure Gene Therapy.心力衰竭基因治疗的现状

J Am Heart Assoc. 2019 May 21;8(10):e012239. doi: 10.1161/JAHA.119.012239.

Introducing Genes to the Heart: All About Delivery.向心脏导入基因：一切关于递送。

Circ Res. 2017 Jan 6;120(1):33-35. doi: 10.1161/CIRCRESAHA.116.310039.

Advances in gene-based therapy for heart failure.心力衰竭的基因治疗进展。

J Cardiovasc Transl Res. 2008 Jun;1(2):127-36. doi: 10.1007/s12265-008-9022-4. Epub 2008 May 29.

Targeted gene therapy for the treatment of heart failure.靶向基因治疗心力衰竭。

Can J Cardiol. 2011 May-Jun;27(3):265-83. doi: 10.1016/j.cjca.2011.02.005.

Advances in gene therapy for heart failure.心力衰竭基因治疗的进展。

Discov Med. 2015 Apr;19(105):285-91.

The current status of clinical gene therapy.临床基因治疗的现状。

Hum Gene Ther. 2002 Jul 20;13(11):1261-2. doi: 10.1089/104303402760128496.

The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical Perspective.心力衰竭的SERCA基因治疗的现状与未来前景：临床视角

Hum Gene Ther. 2015 May;26(5):293-304. doi: 10.1089/hum.2015.018.

Gene therapy for the treatment of heart failure: promise postponed.用于治疗心力衰竭的基因疗法：希望延迟。

Eur Heart J. 2016 Jun 1;37(21):1651-8. doi: 10.1093/eurheartj/ehw019. Epub 2016 Feb 27.

Cardiac gene therapy.心脏基因治疗。

Semin Thorac Cardiovasc Surg. 2010 Summer;22(2):127-39. doi: 10.1053/j.semtcvs.2010.09.009.

Percutaneous approaches for efficient cardiac gene delivery.经皮途径实现高效心脏基因转导。

J Cardiovasc Transl Res. 2013 Aug;6(4):649-59. doi: 10.1007/s12265-013-9479-7. Epub 2013 Jun 8.

引用本文的文献

AAV9-cBIN1 gene therapy rescues chronic heart failure due to ischemic cardiomyopathy in a canine model.腺相关病毒9型-cBIN1基因疗法可挽救犬类模型中因缺血性心肌病导致的慢性心力衰竭。

Commun Med (Lond). 2025 Mar 27;5(1):93. doi: 10.1038/s43856-025-00787-w.

Gene therapy for the heart: encapsulated viruses to the rescue.心脏的基因治疗：封装病毒来救援。

Extracell Vesicles Circ Nucl Acids. 2024 Feb 26;5(1):114-118. doi: 10.20517/evcna.2023.70. eCollection 2024.

Cardiac bridging integrator 1 gene therapy rescues chronic non-ischemic heart failure in minipigs.心脏桥接整合因子1基因疗法可挽救小型猪的慢性非缺血性心力衰竭。

NPJ Regen Med. 2024 Dec 10;9(1):36. doi: 10.1038/s41536-024-00380-0.

When Off-Target the Target: Treating Noncardiomyocytes in Cardiac Laminopathy.当偏离靶点时针对靶点：治疗心脏核纤层蛋白病中的非心肌细胞

JACC Basic Transl Sci. 2024 Nov 25;9(11):1326-1328. doi: 10.1016/j.jacbts.2024.09.012. eCollection 2024 Nov.

Regulation of β-Adrenergic Receptors in the Heart: A Review on Emerging Therapeutic Strategies for Heart Failure.β-肾上腺素受体在心脏中的调控：心力衰竭治疗新策略的综述。

Cells. 2024 Oct 10;13(20):1674. doi: 10.3390/cells13201674.

Advances in the Insulin-Heart Axis: Current Therapies and Future Directions.胰岛素-心脏轴的进展：当前治疗方法和未来方向。

Int J Mol Sci. 2024 Sep 22;25(18):10173. doi: 10.3390/ijms251810173.

Functional analysis of a common BAG3 allele associated with protection from heart failure.常见 BAG3 等位基因与心力衰竭保护相关的功能分析。

Nat Cardiovasc Res. 2023 Jul;2(7):615-628. doi: 10.1038/s44161-023-00288-w. Epub 2023 Jun 26.

Precision Genetic Therapies: Balancing Risk and Benefit in Patients with Heart Failure.精准基因治疗：心力衰竭患者的风险与获益平衡。

Curr Cardiol Rep. 2024 Sep;26(9):973-983. doi: 10.1007/s11886-024-02096-5. Epub 2024 Aug 7.

Progress in the treatment of diabetic cardiomyopathy, a systematic review.糖尿病心肌病的治疗进展：系统评价。

Pharmacol Res Perspect. 2024 Apr;12(2):e1177. doi: 10.1002/prp2.1177.

Emerging Strategies and Effective Prevention Measures for Investigating the Association Between Stroke and Sudden Cardiac Fatality.探索中风与心源性猝死之间关联的新兴策略和有效预防措施。

Curr Cardiol Rev. 2024;20(3):35-44. doi: 10.2174/011573403X259676231222053709.

本文引用的文献

Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations.BAG3 相关扩张型心肌病

J Am Coll Cardiol. 2018 Nov 13;72(20):2471-2481. doi: 10.1016/j.jacc.2018.08.2181.

Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals.BAG3 变异与非裔美国人个体中心肌病结局的关联。

JAMA Cardiol. 2018 Oct 1;3(10):929-938. doi: 10.1001/jamacardio.2018.2541.

Effects of Urocortin 2 Versus Urocortin 3 Gene Transfer on Left Ventricular Function and Glucose Disposal.促肾上腺皮质激素释放因子2与促肾上腺皮质激素释放因子3基因转移对左心室功能和葡萄糖代谢的影响。

JACC Basic Transl Sci. 2018 May 30;3(2):249-264. doi: 10.1016/j.jacbts.2017.12.004. eCollection 2018 Apr.

Urocortin 3 Gene Transfer Increases Function of the Failing Murine Heart.尿皮质素 3 基因转移增加衰竭的小鼠心脏功能。

Hum Gene Ther. 2019 Jan;30(1):10-20. doi: 10.1089/hum.2018.103. Epub 2018 Oct 2.

The Multifunctional Protein BAG3: A Novel Therapeutic Target in Cardiovascular Disease.多功能蛋白BAG3：心血管疾病中的新型治疗靶点。

JACC Basic Transl Sci. 2018 Feb;3(1):122-131. doi: 10.1016/j.jacbts.2017.09.009.

Design of a Phase 3 trial of intracoronary administration of human adenovirus 5 encoding human adenylyl cyclase type 6 (RT-100) gene transfer in patients with heart failure with reduced left ventricular ejection fraction: The FLOURISH Clinical Trial.RT-100 基因转导治疗心力衰竭伴射血分数降低患者的 III 期临床试验设计：FLOURISH 临床试验。

Am Heart J. 2018 Jul;201:111-116. doi: 10.1016/j.ahj.2018.04.005. Epub 2018 Apr 6.

Adeno-Associated Virus Gene Therapy: Translational Progress and Future Prospects in the Treatment of Heart Failure.腺相关病毒基因治疗：心力衰竭治疗中的转化进展与未来前景

Heart Lung Circ. 2018 Nov;27(11):1285-1300. doi: 10.1016/j.hlc.2018.03.005. Epub 2018 Mar 17.

The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice.AAV-PHP.B 的神经嗜性仅限于 C57BL/6J 小鼠。

Mol Ther. 2018 Mar 7;26(3):664-668. doi: 10.1016/j.ymthe.2018.01.018. Epub 2018 Feb 2.

Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN.在高剂量静脉内给予表达人 SMN 的腺相关病毒载体后，非人类灵长类动物和仔猪出现严重毒性。

Hum Gene Ther. 2018 Mar;29(3):285-298. doi: 10.1089/hum.2018.015. Epub 2018 Feb 12.

AAV-9 mediated phosphatase-1 inhibitor-1 overexpression improves cardiac contractility in unchallenged mice but is deleterious in pressure-overload.腺相关病毒 9 介导的磷酸酶 1 抑制剂-1 过表达可改善未受挑战的小鼠的心脏收缩力，但在压力超负荷时则具有损伤性。

Gene Ther. 2018 Jan;25(1):13-19. doi: 10.1038/gt.2017.97. Epub 2018 Jan 19.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验